系统性红斑狼疮患者带状疱疹的危险因素
该研究基于224例系统性红斑狼疮(SLE)患者,评估带状疱疹(HZ)的危险因素。HZ发生率为13.4%,多因素分析显示仅γ球蛋白水平与HZ独立相关(OR 0.86,95%CI 0.74-0.98),阈值10.3 g/L可最佳区分HZ患者。
要点
- SLE患者HZ发生率为13.4%,发病密度0.81/100患者年。
- γ球蛋白水平降低与HZ独立相关,阈值10.3 g/L。
- 糖皮质激素疗程、免疫抑制剂及生物制剂在单因素中与HZ相关。
核心结论
- γ球蛋白水平降低(阈值10.3 g/L)与SLE患者带状疱疹相关,可能识别应优先接种VZV疫苗的患者。
主要发现
- 30例(13.4%)发生HZ,发病密度0.81/100患者年。
- 单因素分析显示γ球蛋白水平(OR 0.81,95%CI 0.70-0.92)、激素疗程(OR 1.07,95%CI 1.03-1.11)、免疫抑制剂(OR 2.41,95%CI 1.06-6.05)、免疫抑制剂疗程(OR 1.05,95%CI 1.00-1.09)及生物制剂(OR 3.50,95%CI 1.53-7.93)与HZ相关。
- 多因素分析仅γ球蛋白水平与HZ独立相关(OR 0.86,95%CI 0.74-0.98)。
- γ球蛋白水平ROC曲线AUC为0.71(95%CI 0.59-0.82),阈值10.3 g/L区分最佳。
关键数值与推荐
- γ球蛋白阈值10.3 g/L可最佳区分SLE患者有无HZ。
临床怎么用
- 对SLE患者可检测γ球蛋白水平,低于10.3 g/L者考虑优先接种VZV疫苗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: International guidelines state that all immunocompromised adults should be vaccinated with the recombinant varicella zoster virus (VZV) vaccine. We aimed to assess the risk factors for herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE). METHODS: Electronic medical records of all SLE patients registered at our referral centre were analysed at the time of clinical visit between July and December 2024. Demographic, medical history, laboratory and treatment data were extracted using a standardised data collection form. Herpes zoster incidence and associated factors were identified. RESULTS: A total of 224 SLE patients (female 93.8 %, median age 48 [38;56] years) were included. Of these, 30 (n = 30/224, 13.4 %) had HZ. The incidence was 0.81 for 100 patient-years. Univariable analysis showed that gamma globulin level (OR 0.81, 95 %CI 0.70-0.92), duration of steroid treatment (OR 1.07, 95 % CI 1.03-1.11), immunosuppressive (IS) drugs (OR 2.41, 95 % CI 1.06-6.05), duration of IS treatment (OR 1.05, 95 % CI 1.00-1.09) and biologics (OR 3.50, 95 % CI 1.53-7.93) were significantly associated with HZ. In a multivariable logistic regression analysis, only gamma globulin level (OR 0.86, 95 % CI 0.74-0.98) remained independently associated with HZ. The ROC curve for gamma globulin levels showed significant associations with HZ (AUC = 0.71 (0.59-0.82)), with a threshold of 10.3 g/L providing the best discrimination between SLE patients with and without HZ. CONCLUSION: A reduced level gammaglobulin - with a cut-off of 10.3 g/L - is associated with HZ in SLE and may identify SLE patients who should be prioritized for VZV vaccination.
引用
- Mageau A, Shala V, David C, et al. Risk factors for herpes zoster in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2026. PMID: 41610674. doi:10.1016/j.semarthrit.2026.152934
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。